SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PureTech Presents Phase 1b LYT-200 Results at ESMO 2026

PureTech said results from the Phase 1b clinical trial of LYT-200 were presented in an oral session at ESMO 2026.

PRTC

Related stories